
Medical Device R&D and Manufacturer

Source: ME+DI, compiled by the Alliance
On June 15, 2026, Johnson & Johnson announced that it wouldInvestment Exceeding $1 Billion, expanding its manufacturing facility in Jacksonville, Florida.

This investment targets core consumer healthcare products—ACUVUE Contact Lenses, including the construction of a new distribution center and the introduction of advanced manufacturing and packaging technologies, is expected toFull production will commence in 2028.
Johnson & Johnson’s ties to Jacksonville date back to 1981. Over the past 44 years, the city has become a core manufacturing hub for Johnson & Johnson’s Vision Care business."This investment reinforces our long-held belief that advanced manufacturing in the United States is essential to delivering innovative, high-quality healthcare solutions to patients worldwide,"Johnson & Johnson Chairman and CEO Joaquin Duato stated in a statement."By further strengthening our vision care business in Jacksonville,"We are enhancing the resilience of the U.S. supply chain."
Top-tier pharmaceutical company,
Intensive Deployment of Local Manufacturing
This investment is not an isolated move. Since 2026,Johnson & Johnson Intensifies Its Manufacturing Footprint in the United States.

Combined Total of Two InvestmentsOver $3 billion, together with the current Jacksonville expansion, are all included in Johnson & Johnson’s previously committed$55 Billion U.S. Investment Plan(Covering manufacturing, R&D, and technology, continuing until early 2029)。
Johnson & Johnson MedTech Global Sales in Q1 2026$8.6 billion, year-on-year growth4.6%, with growth in the US market5.9%, overseas increase3.2%。
Johnson & Johnson Is Not the Only OneA Medical Giant Expanding Production on a Large Scale in the United States.Geopolitical Pressures and Various Uncertainties Are Reshaping the Global Manufacturing Landscape:
Eli Lilly Investment$27 billionConstruction of 4 new factories in the United States;
AstraZeneca Additional$2 billionFor manufacturing and R&D;
Apple Announces$500 billionUS Investment Plan (Including Wearable Medical Devices);
Senator Rick Scott stated bluntly, “A $1 billion investment means a stronger national economy,”Reduced Reliance on Foreign Medical Products。"
Johnson & Johnson’s latest expansion, ostensibly a facility upgrade,Underlying LogicIt is a strategic bet on the resilience of domestic manufacturing at a time when supply chain security has become a core element of competition.
As global giants bring production capacity back to their home countries,Supply Strategy, Pricing System, and Pace of Domestic Substitution in the Chinese Market, will all usher in new variables.
This article is republished for sharing purposes only. The views expressed herein are solely those of the original author and do not represent the position of this platform. Any overlap with original content published on your platform, or any unauthorized use, stems from actions taken by the original platform; this platform merely reposts the content. Should you identify any such issues, please contact us immediately, and we will promptly remove the article upon request.
